BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah LM, Tehrani A, Bushman LR, Anderson PL, Kiser JJ. Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study. Open Forum Infect Dis 2021;8:ofaa564. [PMID: 33447634 DOI: 10.1093/ofid/ofaa564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nicolini LA, Menzaghi B, Molteni C, Vichi F, Cascio A, Parisini A, De Socio GV, Falasca K, Bonfanti P, Di Biagio A. Comments on "Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C". J Med Virol 2022;94:436-8. [PMID: 34499359 DOI: 10.1002/jmv.27329] [Reference Citation Analysis]
2 Turcu-Stiolica A, Doica IP, Ungureanu BS, Rogoveanu I, Florescu DN, Subtirelu MS, Gheonea DI. Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C. Pharmaceutics 2021;13:1683. [PMID: 34683976 DOI: 10.3390/pharmaceutics13101683] [Reference Citation Analysis]
3 Dhiman RK, Grover GS, Premkumar M, Roy A, Taneja S, Duseja A, Arora S; MMPHCRF Investigators. Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model. EClinicalMedicine 2021;41:101148. [PMID: 34712928 DOI: 10.1016/j.eclinm.2021.101148] [Reference Citation Analysis]
4 Berkan-Kawińska A, Piekarska A, Janczewska E, Lorenc B, Tudrujek-Zdunek M, Tomasiewicz K, Berak H, Horban A, Zarębska-Michaluk D, Pabjan P, Buczyńska I, Pazgan-Simon M, Dybowska D, Halota W, Pawłowska M, Klapaczyński J, Mazur W, Czauż-Andrzejuk A, Socha Ł, Laurans Ł, Garlicki A, Sitko M, Jaroszewicz J, Citko J, Dobracka B, Krygier R, Białkowska-Warzecha J, Tronina O, Belica-Wdowik T, Baka-Ćwierz B, Flisiak R. Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study. Liver Int 2021;41:1789-801. [PMID: 33655628 DOI: 10.1111/liv.14858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]